Pure Global

Specimen receptacle IVDs

Access comprehensive regulatory information for Specimen receptacle IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Emergo Asia Pacific Pty Ltd T/a Emergo Australia, manufactured by Genomic Health Inc in United States of America. The device registration started on August 07, 2014.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class I
Class I
Specimen receptacle IVDs
Australia TGA ARTG Registered Device
Good Name: Emergo Asia Pacific Pty Ltd T/a Emergo Australia - Specimen receptacle IVDs
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The purpose of the Oncotype DX kit is to transport formalin fixed paraffin embedded tumor (FFPET) samples to Genomic Health Inc. in the United States for processing. FFPET samples are non-biohazardous, non-infectious, non-liquid, and stable at room temperature. Users have the option of providing FFPET samples as blocks or as block sections added to a slide. The kit contains zip closure bags, a foam insert, a slide mailer (for samples provided as block sections), and a gel ice pack (for samples provided as blocks).

Device Classification
Risk Class
Class I
Product Type
IVD
ARTG Category
IVD
Registration Information
Start Date
August 07, 2014
Effective Date
August 07, 2014
Manufacturer
Country
United States of America
Address
301 Penobscot Drive, Redwood City, CA, 94063